Most cited papers from Action Cancer

Action Cancer

What are the most cited papers from Action Cancer?

The most cited paper from Action Cancer is "Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data" (Michel P. Coleman et al., 2010), with 1,131 citations. Next come "Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007" (579) and "UK health performance: findings of the Global Burden of Disease Study 2010" (561).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 7 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Michel P. Coleman et al. · The Lancet Open access	22 Dec 2010	1,131
2	Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007 Sarah Walters et al. · Thorax Open access	11 Feb 2013	579
3	UK health performance: findings of the Global Burden of Disease Study 2010 Christopher J L Murray et al. · The Lancet	Mar 2013	561
4	Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets Lucy Elliss‐Brookes, Sean McPhail, Alexander Ives et al. · British Journal of Cancer Open access	20 Sep 2012	537
5	Multidisciplinary team working in cancer: what is the evidence? Chris Taylor, Alice Munro, Rob Glynne‐Jones et al. · BMJ Open access	23 Mar 2010	479
6	Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study The ICBP Module 1 Working Group20 et al. · British Journal of Cancer Open access	28 Feb 2013	249
7	The size of the prize for earlier diagnosis of cancer in England M A Richards · British Journal of Cancer Open access	Dec 2009	229
8	The National Awareness and Early Diagnosis Initiative in England: assembling the evidence Martin Richards · British Journal of Cancer Open access	3 Dec 2009	221
9	Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking Partnership Camille Maringe, Sarah Walters, John Butler et al. · Gynecologic Oncology	27 Jun 2012	215
10	Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007 Camille Maringe et al. · Acta Oncologica Open access	15 Apr 2013	207
11	Risk factors for delay in symptomatic presentation: a survey of cancer patients Lindsay J L Forbes, Fiona G. Warburton, M A Richards et al. · British Journal of Cancer Open access	10 Jun 2014	185
12	Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA Michael Jefford, Julia Howe Rowland, Eva Grunfeld et al. · British Journal of Cancer Open access	20 Dec 2012	162
13	Enhanced recovery from surgery in the UK: an audit of the enhanced recovery partnership programme 2009–2012 Joanna C Simpson, Ramani Moonesinghe, Michael P. W. Grocott et al. · British Journal of Anaesthesia Open access	29 Apr 2015	159
14	Cancer recording and mortality in the General Practice Research Database and linked cancer registries Rachael Boggon, Tjeerd Pieter van Staa, Michael Chapman et al. · Pharmacoepidemiology and Drug Safety	13 Dec 2012	135
15	The International Cancer Benchmarking Partnership: An international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom John Butler, Catherine Foot, Martine Bomb et al. · Health Policy Open access	18 May 2013	105
16	Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group Allison M. Magnuson, Suanna S. Bruinooge, Harpreet Singh et al. · Clinical Cancer Research Open access	9 Feb 2021	90
17	Variation in use of the 2-week referral pathway for suspected cancer: A cross-sectional analysis David Meechan, Carolynn Gildea, Louise Hollingworth et al. · British Journal of General Practice Open access	27 Aug 2012	86
18	The English National Low Rectal Cancer Development Programme: key messages and future perspectives Brendan John Moran, T. Holm, G. Brannagan et al. · Colorectal Disease	24 Nov 2013	69
19	Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study Richard T. Bryan, Wenyu Liu, Sarah J. Pirrie et al. · European Urology Open access	27 Feb 2021	63
20	A Historical Perspective on Breast Cancer Activism in the United States: From Education and Support to Partnership in Scientific Research Janet Rose Osuch, Kami J. Silk, Carole Price et al. · Journal of Women s Health Open access	2 Dec 2011	62
21	Radiotherapy Demand and Activity in England 2006–2020 C. Round, Michael V Williams, T. Mee et al. · Clinical Oncology	12 Jun 2013	53
22	CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer Hugh A. Mostafid, Nuria Sole de Porta, Joanne Cresswell et al. · British Journal of Urology Open access	3 Mar 2020	50
23	Role of general practice in the diagnosis of oral cancer Timothy Crossman, Fiona G. Warburton, Michael A. Richards et al. · British Journal of Oral and Maxillofacial Surgery	15 Dec 2015	47
24	Stereotactic Body Radiotherapy. Guidelines for Commissioners, Providers and Clinicians: a National Report K. Paul Kirkbride, Thomas J. Cooper · Clinical Oncology	9 Feb 2011	45
25	Agenda for Translating Physical Activity, Nutrition, and Weight Management Interventions for Cancer Survivors into Clinical and Community Practice Karen M. Basen-Engquist, Catherine M. Alfano, Melissa Maitin‐Shepard et al. · Obesity Open access	31 Oct 2017	44
26	Extending the Age Range for Breast Screening in England: Pilot Study to Assess the Feasibility and Acceptability of Randomization Kath A Moser, Sarah Sellars, Margot Wheaton et al. · Journal of Medical Screening	Jun 2011	44
27	Factors influencing participation in breast cancer screening Lynne Edgar, Marie Glackin, Caroline Hughes et al. · British Journal of Nursing	2013	42
28	Reciprocal peer review for quality improvement: an ethnographic case study of the Improving Lung Cancer Outcomes Project Emma‐Louise Aveling, Graham Paul Martin, Senai Jiménez García et al. · BMJ Quality & Safety Open access	9 Aug 2012	33
29	Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience Puneet Nagpal, Deep Shankar Pruthi, Manish Kumar Pandey et al. · Oral Oncology	14 Aug 2021	32
30	The work left undone. Understanding the challenge of providing holistic lung cancer nursing care in the UK Alison Leary, John White, Laura Yarnell · European Journal of Oncology Nursing	16 Nov 2013	32
31	Development of an evidence-informed leisure time physical activity resource for adults with spinal cord injury: the SCI Get Fit Toolkit Kelly P. Arbour‐Nicitopoulos, Kathleen A. Martin Ginis, Amy E. Latimer‐Cheung et al. · Spinal Cord	23 Apr 2013	30
32	Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real‐world findings from NHS England between 2013 and 2019 James W.F. Catto, Olena Mandrik, Lewis A. Quayle et al. · British Journal of Urology Open access	21 Jan 2023	28
33	The sex gap in bladder cancer survival — a missing link in bladder cancer care? Paul Toren, Anna C. Wilkins, Keval N. Patel et al. · Nature Reviews Urology ReviewOpen access	21 Aug 2023	23
34	Female sexual function in bladder cancer: A review of the evidence Rebecca Martin, Tessa Renouf, Jeannie Rigby et al. · BJUI Compass Open access	24 Sep 2022	20
35	Variations in Radiotherapy Delivery in England — Evidence from the National Radiotherapy Dataset Peter Hoskin, Helen Forbes, Christine M Ball et al. · Clinical Oncology	12 May 2013	20
36	Understanding the needs of people using a cancer information service in Northern Ireland Douglas Manning, Paula Quigley · European Journal of Cancer Care Open access	Jun 2002	20
37	REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers Sophie Merrick, Matthew Guy Nankivell, Matteo Quartagno et al. · Contemporary Clinical Trials Open access	26 Nov 2022	19
38	Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial Richard T. Bryan et al. · Journal of Clinical Oncology Open access	14 Jan 2025	16
39	Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers Lyon Mascarenhas, Susan Shanley, Gillian Mitchell et al. · Asia-Pacific Journal of Clinical Oncology Open access	7 Oct 2018	16
40	Breast self examination: be alert but not alarmed? Sally Crossing, Rosetta Manaszewicz · The Medical Journal of Australia	Jun 2003	16
41	A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members Cath Taylor, Joanna M Sippitt, Professor Gary S. Collins et al. · BMC Health Services Research Open access	29 Jun 2010	16
42	Diversity of fruit fly (Diptera: Tephritidae) species in French Guiana: their main host plants and associated parasitoids during the period 1994–2003 and prospects for management Jean‐François Vayssières, J. P. Cayol, P. Caplong et al. · Fruits Open access	May 2013	16
43	Alternatives to hormone replacement for menopause. V M Soffa · PubMed	Mar 1996	16
44	Are Cancer Survivors Willing to Participate in Research? Berta M. Geller, John L. Mace, Pamela M. Vacek et al. · Journal of Community Health	10 Feb 2011	15
45	Progress with Intensity-modulated Radiotherapy Implementation in the UK W. P. M. Mayles, Thomas J. Cooper, Ranald I. Mackay et al. · Clinical Oncology	12 Jul 2012	14
46	Struma Ovarii with Elevated Ca-125 Levels and Ascites Mimicking Advanced Ca Ovary Navin Kumar Sinha · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH Open access	2014	14
47	The Malthus Programme: Developing Radiotherapy Demand Models for Breast and Prostate Cancer at the Local, Regional and National Level C. Round, T. Mee, Norman Francis Kirkby et al. · Clinical Oncology	19 Jun 2013	13
48	Who accesses complementary therapies and why?: An evaluation of a cancer care service Michael Matthews, Marie Glackin, Caroline Hughes et al. · Complementary Therapies in Clinical Practice	29 Nov 2014	12
49	Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer Sudeep Gupta, Manish Kumar Singh, Amish Vora et al. · South Asian Journal of Cancer Open access	Apr 2018	11
50	HPV vaccine attitudes and practices among primary care providers in Appalachian Pennsylvania. Nicole L. Huey, Allison D. Clark, Brenda Coffey Kluhsman et al. · PubMed Open access	Apr 2009	11

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.